Concentrically expanded reversed halo sign caused by nivolumab-related pneumonia.

Tokuyasu, Hirokazu; Sato, Yoshitoshi; Sueda, Yuriko; Sakai, Hiromitsu; Esumi, Chika; Yamasaki, Akira

Tokuyasu, Hirokazu; Sato, Yoshitoshi; Sueda, Yuriko; Sakai, Hiromitsu; Esumi, Chika; Yamasaki, Akira.

Afiliação

Tokuyasu H; Department of Respiratory Medicine Matsue Red Cross Hospital Matsue Japan.
Sato Y; Department of Surgery Matsue Red Cross Hospital Matsue Japan.
Sueda Y; Department of Respiratory Medicine Matsue Red Cross Hospital Matsue Japan.
Sakai H; Department of Respiratory Medicine Matsue Red Cross Hospital Matsue Japan.
Esumi C; Department of Pathology Matsue Red Cross Hospital Matsue Japan.
Yamasaki A; Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, School of Medicine, Faculty of Medicine Tottori University Yonago Japan.

Respirol Case Rep ; 12(5): e01352, 2024 May.

Article em En | MEDLINE | ID: mdl-38736507

ABSTRACT

ABSTRACT

Among immune-related adverse events, pneumonitis is relatively uncommon, and nivolumab-related pneumonitis may present with a reversed halo sign.

Palavras-chave

chemotherapy; nivolumab; oesophageal squamous cell carcinoma; organizing pneumonia; reversed halo sign

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Respirol Case Rep Ano de publicação: 2024 Tipo de documento: Article